These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 36915738)
1. Clinical characteristics and survival analysis of class I pulmonary arterial hypertension. Zheng L; Yang Y; Zhao W; Yang H; Zhan H; Zhao Y; Jiang R Am J Transl Res; 2023; 15(2):1476-1484. PubMed ID: 36915738 [TBL] [Abstract][Full Text] [Related]
2. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease]. Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483 [No Abstract] [Full Text] [Related]
3. [Analysis of high risk factors for patient death and its clinical characteristics on pregnancy associated with pulmonary arterial hypertension]. Bao Z; Zhang J; Yang D; Xu X Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):495-500. PubMed ID: 25327730 [TBL] [Abstract][Full Text] [Related]
4. Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD. Zhu T; Wu P; Tan Z; Jin Q; Chen Y; Li L; Chen Z; Tang Y; Li J; Fang Z Front Pharmacol; 2023; 14():1124746. PubMed ID: 36860300 [No Abstract] [Full Text] [Related]
5. Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors. Gu L; Li YY; Gu L; Xie L; Liu HM Front Pediatr; 2020; 8():106. PubMed ID: 32296664 [No Abstract] [Full Text] [Related]
6. Clinical use of macitentan in the treatment of connective tissue disease-associated pulmonary arterial hypertension. Song X; Sheng X; Ding L; Wu J; Chang X; Zhou E; Cao J; Cheng T; Wang M J Thorac Dis; 2024 Mar; 16(3):2060-2069. PubMed ID: 38617769 [TBL] [Abstract][Full Text] [Related]
7. [Value of four-dimensional echocardiography combined with speckle tracking technique on the assessment of right heart function and prognosis in patients with pulmonary arterial hypertension]. Zhang XM; Zhuang Q; Yang MH; Wang W; Zheng Y; Qiao ZQ; Shen JY; Shen XD Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Dec; 46(12):965-971. PubMed ID: 30572401 [No Abstract] [Full Text] [Related]
8. [Clinical characteristics of 195 Chinese patients with WHO Class I pulmonary hypertension]. Zhang G; Shang X; Deng X; Zhou H Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1001-5. PubMed ID: 25623345 [TBL] [Abstract][Full Text] [Related]
9. [Classification, diagnosis and treatment status of pulmonary hypertension from 2012 to 2019: a single center study in Yunnan province]. Feng XL; Lu YB; Yang D; Xue Q; Zhang JL; Lin CR; Gan P; Zhang WH; Guang XF; Dai HL Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Nov; 51(11):1188-1193. PubMed ID: 37963755 [No Abstract] [Full Text] [Related]
10. [Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension]. Liu Q; Zhang C; Li QQ; Zhu Y; Zhang D; Zhao WG; Gu H Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):23-28. PubMed ID: 29342993 [No Abstract] [Full Text] [Related]
11. Exercise pathophysiology differs between connective tissue diseases-associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension. Zhang Y; Jin Q; Zhao Z; Zhao Q; Yu X; Yan L; Li X; An C; Ma X; Xiong C; Luo Q; Liu Z Clin Exp Rheumatol; 2021; 39(5):1063-1070. PubMed ID: 33200733 [TBL] [Abstract][Full Text] [Related]
12. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension. Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry. Chazova IE; Arkhipova OA; Martynyuk TV Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367 [TBL] [Abstract][Full Text] [Related]
14. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension. Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486 [TBL] [Abstract][Full Text] [Related]
15. Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking. Bai Y; Yang J; Liu J; Ning H; Zhang R Int J Cardiovasc Imaging; 2019 Sep; 35(9):1637-1649. PubMed ID: 31037473 [TBL] [Abstract][Full Text] [Related]
16. [Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension]. Zhao Q; Liu Z; Ma X; Zhao Z; Luo Q; Gu Q; Xiong C; Zhang H; Wang Y Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3598-601. PubMed ID: 26813372 [TBL] [Abstract][Full Text] [Related]
17. Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry. Xie F; Quan R; Zhang G; Tian H; Chen Y; Yu Z; Zhang C; Liu Y; Zhu X; Wu W; Zhu X; Yang Z; Gu Q; Xiong C; Han H; Cheng Y; He J; Wu Y J Heart Lung Transplant; 2023 Jul; 42(7):974-984. PubMed ID: 37002152 [TBL] [Abstract][Full Text] [Related]
18. Predicting the Need for Upfront Combination Therapy in Pulmonary Arterial Hypertension. Bajwa AA; Qureshi T; Shujaat A; Seeram V; Jones LM; Al-Saffar F; Cury JD J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):395-400. PubMed ID: 25613465 [TBL] [Abstract][Full Text] [Related]
19. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension. Kylhammar D; Persson L; Hesselstrand R; Rådegran G Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571 [TBL] [Abstract][Full Text] [Related]
20. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry). Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]